BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Buur LM, Declercq A, Strobl M, et al. (2024) MSRescore 3.0 Is a Modular, Flexible, and User-Friendly Platform to Boost Peptide Identifications, as Showcased with MS Amanda 3.0. Journal of Proteome Research |
Declercq A, Bouwmeester R, Chiva C, et al. (2023) Updated MS²PIP web server supports cutting-edge proteomics applications. Nucleic Acids Research |
Boone M, Ramasamy P, Zuallaert J, et al. (2023) Author Correction: Massively parallel interrogation of protein fragment secretability using SECRiFY reveals features influencing secretory system transit. Nature Communications. 14: 1072 |
Neely BA, Dorfer V, Martens L, et al. (2023) Toward an Integrated Machine Learning Model of a Proteomics Experiment. Journal of Proteome Research |
Gabriels R, Declercq A, Bouwmeester R, et al. (2022) psm_utils: A High-Level Python API for Parsing and Handling Peptide-Spectrum Matches and Proteomics Search Results. Journal of Proteome Research |
Declercq A, Bouwmeester R, Hirschler A, et al. (2022) MSRescore: Data-driven rescoring dramatically boosts immunopeptide identification rates. Molecular & Cellular Proteomics : McP. 100266 |
Delhaye L, De Bruycker E, Volders PJ, et al. (2022) Orthogonal proteomics methods to unravel the HOTAIR interactome. Scientific Reports. 12: 1513 |
Boone M, Ramasamy P, Zuallaert J, et al. (2021) Massively parallel interrogation of protein fragment secretability using SECRiFY reveals features influencing secretory system transit. Nature Communications. 12: 6414 |
Bouwmeester R, Gabriels R, Hulstaert N, et al. (2021) DeepLC can predict retention times for peptides that carry as-yet unseen modifications. Nature Methods. 18: 1363-1369 |
Van Puyvelde B, Van Uytfanghe K, Tytgat O, et al. (2021) Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients. Jacs Au. 1: 750-765 |